I am a
Home I AM A Search Login

Papers of the Week

Papers: 3 Oct 2020 - 9 Oct 2020

Human Studies, Pharmacology/Drug Development


2020 Oct 07

Pain Ther

Benefits Beyond Headache Days With OnabotulinumtoxinA Treatment: A Pooled PREEMPT Analysis.


Diener H-C, Dodick DW, Lipton RB, Adams A M, Degryse RE, Silberstein SD
Pain Ther. 2020 Oct 07.
PMID: 33026631.


The double-blind, phase 3 PREEMPT trials demonstrated the efficacy and tolerability of onabotulinumtoxinA for headache prevention in adults with chronic migraine. This post hoc analysis evaluated the effect of onabotulinumtoxinA on clinically meaningful changes in headache severity, headache-related impact, and quality of life.